RADNOR, Pa. & GÖTEBORG, Sweden--(BUSINESS WIRE)--Cortendo AB, a global biopharmaceutical company, has entered into agreements with RA Capital, NEA, Broadfin Capital and HealthCap and raises up to $27.5M in additional private placement.